Pharmacologic and Toxicologic Evaluation of C. novyi-NT Spores
Open Access
- 14 September 2005
- journal article
- research article
- Published by Oxford University Press (OUP) in Toxicological Sciences
- Vol. 88 (2) , 562-575
- https://doi.org/10.1093/toxsci/kfi316
Abstract
Clostridium novyi-NT (C. novyi-NT) spores have been shown to be potent therapeutic agents in experimental tumors of mice and rabbits. In the present study, pharmacologic and toxicologic studies were performed to better understand the factors influencing the efficacy and toxicity of this form of therapy. We found that spores were rapidly cleared from the circulation by the reticuloendothelial system. Even after large doses were administered, no clinical toxicity was observed in healthy mice or rabbits. The spores were also not toxic in mice harboring poorly vascularized non-neoplastic lesions, including myocardial infarcts. In tumor-bearing mice, toxicity appeared related to tumor size and spore dose, as expected with any bacterial infection. However, there was no laboratory or histopathologic evidence of sepsis, and the toxicity could be effectively controlled by simple hydration.Keywords
This publication has 37 references indexed in Scilit:
- Bacteriolytic therapy can generate a potent immune response against experimental tumorsProceedings of the National Academy of Sciences, 2004
- Colorectal carcinoma in endoscopic biopsies; additional histologic criteria for the diagnosisPathology - Research and Practice, 2004
- Surviving Sepsis Campaign guidelines for management of severe sepsis and septic shockCritical Care Medicine, 2004
- Targeting Vascular and Avascular Compartments of Tumors withC. novyi-NTand Anti-microtubule AgentsCancer Biology & Therapy, 2004
- Overcoming the hypoxic barrier to radiation therapy with anaerobic bacteriaProceedings of the National Academy of Sciences, 2003
- Macrophages of the Splenic Marginal Zone Are Essential for Trapping of Blood-Borne Particulate Antigen but Dispensable for Induction of Specific T Cell ResponsesThe Journal of Immunology, 2003
- Tumor Microenvironment and the Response to Anticancer TherapyCancer Biology & Therapy, 2002
- Combination bacteriolytic therapy for the treatment of experimental tumorsProceedings of the National Academy of Sciences, 2001
- The Prevention Of Experimental Clostridium Novyi And Cl. Perfringens Gas Gangrene In High-Velocity Missile Wounds By Active ImmunisationJournal of Medical Microbiology, 1972
- The Prevention Of Experimental Clostridium Novyi Gas Gangrene In High-VelociTy Missile Wounds By Passive ImmunisationJournal of Medical Microbiology, 1972